
Person deep dive
Kirk Nielsen
#67 2026 Strebulaev–Jackson Venture Ranking, emerging firms
Kirk Nielsen co-founded Vensana Capital in 2019 to invest in medical technology, after leading the medtech practice at Versant Ventures. He has led or co-led investments in companies that exited, including Inari Medical, which went public, and Vensana closed a $425M third fund in 2025.
- Founded
- Vensana Capital
- Education
- Harvard Business School
Track record
Investments Kirk Nielsen is best known for, with what became of them.
- IInari MedicalLed or co-led the investmentWent public
- CCVRxInvestor and still active with the companyWent public
- SSpyGlass PharmaInvestor and still active with the companyPriced its IPO in February 2026
Vensana Capital
FirmVensana Capital
Founded2019
Based inMinneapolis
Funds$425M Fund III closed in January 2025
FocusMedical technology, from development to commercial stage
Career
- 2006Joined Versant Ventures from Medtronic's Cardiac Rhythm Management division, after working at Fluidigm and Bain & Company and playing professional hockey.
- 2019Co-founded Vensana Capital.
- 2025Vensana closed its third fund at $425M.
- 2026Portfolio company SpyGlass Pharma priced its IPO.
Sources: Vensana Capital: team · Vensana Capital: $425M Fund III (2025) · Vensana Capital: SpyGlass Pharma IPO pricing · Dealroom person profile. Rank: 2026 Strebulaev–Jackson Venture Ranking.
Companies founded

Vensana Capital
Currently
Active roles, board seats and partnerships.
Work history
Past roles by Dealroom records.

National Venture Capital Association

Medtronic
$132B valuation (2026)
→

Bain & Company

Standard Biotools
$257.2M valuation (2026)
→
Education

Harvard Business School
